Detalhe da pesquisa
1.
The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic Review.
Oncologist
; 29(5): e580-e600, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38309719
2.
Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal Mesothelioma: Insights From a Multi-Center Study.
Ann Surg Oncol
; 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38806763
3.
Twelve-month progression-free survival with sotorasib and panitumumab in KRAS G12C mutant metastatic colorectal cancer.
Anticancer Drugs
; 35(5): 459-461, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38451823
4.
Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours-results from a Turkish multi-centre study.
Jpn J Clin Oncol
; 54(5): 562-568, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38271177
5.
Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy.
Int J Clin Oncol
; 29(6): 822-831, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38565751
6.
Sirolimus experience in adult patients with vascular malformations.
Vascular
; : 17085381241241853, 2024 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38523367
7.
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group.
Oncologist
; 28(10): 875-884, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37676712
8.
A chance in hopeless cancer: 5-year complete remission after oxaliplatin-based therapy in a patient with BRCA2 mutant metastatic pancreatic cancer.
Anticancer Drugs
; 34(10): 1190-1192, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36729128
9.
The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors.
Anticancer Drugs
; 34(6): 783-790, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36729111
10.
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer.
Future Oncol
; 19(37): 2445-2452, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37701986
11.
Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatment.
Anticancer Drugs
; 33(1): e477-e485, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34261917
12.
Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study.
Eur J Clin Pharmacol
; 78(12): 1973-1979, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36266366
13.
Classification of early-stage colon cancer with Immunoscore®: clinical evidence and case studies.
Future Oncol
; 18(5): 613-623, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34904905
14.
The benefit of immunotherapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Future Oncol
; 2022 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36533987
15.
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey.
Future Oncol
; 18(29): 3267-3276, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36040321
16.
Examining guidelines and new evidence in oncology nutrition: a position paper on gaps and opportunities in multimodal approaches to improve patient care.
Support Care Cancer
; 30(4): 3073-3083, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34811570
17.
The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapy.
J Oncol Pharm Pract
; 28(4): 785-793, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33878976
18.
Retrospective comparison of flot and modified dcf as first-line chemotherapy in metastatic gastric adenocarcinoma.
Turk J Med Sci
; 52(5): 1559-1568, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36422493
19.
Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group).
Turk J Med Sci
; 52(4): 1022-1032, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36326360
20.
A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience.
Oncologist
; 26(5): e769-e779, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33687747